Skip to contentSkip to Braille Studio

Library / Laws / 114th Congress / House Bills / H.R. 1537

H.R. 1537

To amend the Federal Food, Drug, and Cosmetic Act to reauthorize a program of priority review to encourage treatments for rare pediatric diseases, and for other purposes.

Print stageDateSize⠃
Introduced in House2015-03-232.3K⠃⠗⠋